BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2154790)

  • 1. Characterization of putative kappa opioid-sensitive cells of the substantia nigra pars reticulata.
    Thompson LA; Walker JM
    Prog Clin Biol Res; 1990; 328():335-8. PubMed ID: 2154790
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effects of the kappa opiate U50,488 in the substantia nigra pars reticulata.
    Thompson LA; Walker JM
    Brain Res; 1990 May; 517(1-2):81-7. PubMed ID: 2165438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activity of selective opioid agonists on hypothalamic magnocellular neuronal activity.
    Clarke G; Davison I; MacMillan SJ; Wright DM
    Prog Clin Biol Res; 1990; 328():351-4. PubMed ID: 2154792
    [No Abstract]   [Full Text] [Related]  

  • 4. Involvement of the nigrotectal and nigrothalamic pathways in kappa opioid-induced circling.
    Thompson LA; Walker JM
    Synapse; 1992 Nov; 12(3):189-94. PubMed ID: 1481138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Central depressor effect of U50488H: a highly selective kappa opioid agonist].
    Feng Y; Han JS
    Sheng Li Xue Bao; 1987 Jun; 39(3):305-9. PubMed ID: 2823391
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynorphin prolongs the action potential duration of mouse sensory ganglion neurons by decreasing a K+ conductance whereas the specific kappa opioid, U-50,488H does so by increasing a Ca2+ conductance.
    Shen KF; Crain SM
    Prog Clin Biol Res; 1990; 328():343-6. PubMed ID: 1968268
    [No Abstract]   [Full Text] [Related]  

  • 8. Opposite effects of mu and kappa opiates on the firing-rate of dopamine cells in the substantia nigra of the rat.
    Walker JM; Thompson LA; Frascella J; Friederich MW
    Eur J Pharmacol; 1987 Jan; 134(1):53-9. PubMed ID: 3030781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of kappa opioid mediated effects in the rat by cyclo (Leu-Gly).
    Bhargava HN; Ramarao P
    Prog Clin Biol Res; 1990; 328():493-6. PubMed ID: 2154810
    [No Abstract]   [Full Text] [Related]  

  • 10. Striatonigral prodynorphin: a model system for understanding opioid peptide function.
    Thompson LA; Matsumoto RR; Hohmann AG; Walker JM
    Ann N Y Acad Sci; 1990; 579():192-203. PubMed ID: 2159742
    [No Abstract]   [Full Text] [Related]  

  • 11. Respiratory effects of receptor-selective opioids in rhesus monkeys.
    France CP; Woods JH
    Prog Clin Biol Res; 1990; 328():295-8. PubMed ID: 2154784
    [No Abstract]   [Full Text] [Related]  

  • 12. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists.
    Matsumoto RR; Brinsfield KH; Patrick RL; Walker JM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):196-203. PubMed ID: 2839661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new analysis of whole-body calorimetry data.
    Lynch TJ; Martinez RP; Furman MB; Geller EB; Adler MW
    NIDA Res Monogr; 1989; 95():289-90. PubMed ID: 2561834
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
    Castillo R; Kissin I; Bradley EL
    Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nor-binaltorphimine on the behavior of mice and rats receiving multiple injections of U-50,488.
    Cowan A; Murray CW
    Prog Clin Biol Res; 1990; 328():303-6. PubMed ID: 2154786
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of a novel class of highly potent sigma ligands related to the kappa-selective agonist U50,488.
    Radesca LA; deCosta BR; Bowen WD; DiPaolo LJ; Rice KC
    NIDA Res Monogr; 1990; 105():518-9. PubMed ID: 1652089
    [No Abstract]   [Full Text] [Related]  

  • 18. [Synthesis and analgesic activity of 3,4-dichloro-N-methyl-N-[trans-2-(1-delta 3-pyrrolinyl)-cyclohexyl]-benzenacetamide hydrochloride].
    Ma SC; Lu SN; Li KZ; Wang CQ
    Yao Xue Xue Bao; 1986 Nov; 21(11):861-3. PubMed ID: 3035865
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of mu-, delta- and kappa-opiate receptor agonists on the bioelectrical activity of the viscerosomatic convergent neurons in the posterior horn of the spinal cord].
    Kasparov SA
    Eksp Klin Farmakol; 1993; 56(1):13-6. PubMed ID: 8391888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.